Michael S. Iskra serves as Executive at Ortho Clinical Diagnostics Holdings plc, where they oversee executive responsibilities. Since joining the company, Michael S. Iskra has executed 10 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 1, 2024 involved receiving (via award) 3,594 shares valued at $0.
Michael S. Iskra currently holds 17,944 shares of Ortho Clinical Diagnostics Holdings plc (OCDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael S. Iskra has been a net neutral trader of OCDX stock. They have purchased $0 and sold $0 worth of shares.
Michael S. Iskra's most recent insider trade was on Jun 1, 2024, when they sold 3,594 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $44.19 |
| Discretionary |
| Mar 28, 2024 | QDEL | $85.0K | Payment | 1,773 | $47.94 | Discretionary |
| Mar 28, 2024 | QDEL | $0 | Award | 4,925 | $N/A | Discretionary |
| Jun 1, 2023 | QDEL | $157.5K | Payment | 1,839 | $85.65 | Discretionary |
| Jun 1, 2023 | QDEL | $0 | Award | 3,594 | $N/A | Discretionary |
| Apr 1, 2023 | QDEL | $0 | Award | 15,825 | $N/A | Discretionary |
| Apr 1, 2023 | QDEL | $617.4K | Payment | 6,930 | $89.09 | Discretionary |
| May 27, 2022 | OCDX | $0 | Disposition | 150,000 | $N/A | Discretionary |
| May 21, 2021 | OCDX | $0 | Award | 150,000 | $N/A | Discretionary |